Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants-Reference-Cited by-同舟云学术

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants

Published:2006-12-24 Issue:1 Volume:13 Page:100-106
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Fischer Will,Perkins Simon,Theiler James,Bhattacharya Tanmoy,Yusim Karina,Funkhouser Robert,Kuiken Carla,Haynes Barton,Letvin Norman L,Walker Bruce D,Hahn Beatrice H,Korber Bette T

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1461.pdf

Reference32 articles.

1. Nabel, G.J. HIV vaccine strategies. Vaccine 20, 1945–1947 (2002).

2. Altfeld, M. et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420, 434–439 (2002).

3. Gaschen, B. et al. Diversity considerations in HIV-1 vaccine selection. Science 296, 2354–2360 (2002).

4. Korber, B. et al. Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. 58, 19–42 (2001).

5. Williamson, C. et al. Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res. Hum. Retroviruses 19, 133–144 (2003).

Cited by 374 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study;eBioMedicine;2024-10

2. mRNA-based HIV-1 vaccines;Clinical Microbiology Reviews;2024-09-12

3. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02

4. Human Immunodeficiency Virus Vaccine;Infectious Disease Clinics of North America;2024-09

5. The effects of high shear rates on the average hydrodynamic diameter measured in biomimetic HIV Gag virus-like particle dispersions;Frontiers in Bioengineering and Biotechnology;2024-05-27